Market Tracker

10/20 5:16pm ET

Intellipharmaceutics International Inc (NASDAQ:IPCI)

1.00
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
0.81
Today|||52-Week Range
3.35
-64.79%
Year-to-Date
New Strong Sell Stocks for October 11th
Oct 11 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close1.00
Today’s open0.99
Day’s range0.98 - 1.03
Volume153,839
Average volume (3 months)390,935
Market cap$31.1M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-22.58%
Earnings growth (this year)+45.61%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)-45.11%
P/E ratio--
Price/Sales32.70
Price/Book26.69

Competitors

 Today’s
change
Today’s
% change
SLNOSoleno Therapeutics ...-0.09-4.07%
CTXRCitius Pharmaceutica...+0.04+1.45%
VKTXViking Therapeutics ...+0.02+0.67%
ADHDAlcobra Ltd+0.08+5.30%
Data as of 4:00pm ET, 10/20/2017

Financials

Next reporting dateFebruary 8, 2018
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$2.2M
Annual profit (last year)-$10.1M
Net profit margin-451.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO &
Co-Chief Scientific Officer
Isa Odidi
President, Chief Operating Officer &
Director
Amina Odidi
Corporate headquarters
Toronto, Ontario

Forecasts